Patent · US Active

Anti-B7-H1 antibodies for treating tumors

US10829557B2 · kind B2 · utility

1Cited by
2References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2019
Grant dateNov 10, 2020
Priority date—
Expiry dateMay 21, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70532
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.